Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,432,191 |
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on... |
| US-5,432,190 |
Pharmaceutical compositions containing triazoles and method of treating
estrogen-dependent diseases Azole derivatives (including stereoisomers and pharmaceutically acceptable salts) of the formula: ##STR1## wherein R.sub.1 and R.sub.2 each are H or C.sub.1... |
| US-5,432,189 |
Bis-aryl amide and urea antagonists of platelet activating factor Bis-aryl amide and urea compounds of the general formula: ##STR1## wherein X is a divalent amide or urea substituent and Y is a nitrogen containing... |
| US-5,432,188 |
4-heteroaryl- and 4-aryl-1,4-dihydropyridine compounds There are provided novel 1,4-dihydropyridine compounds, compositions containing them and methods of using them to treat congestive heart failure. |
| US-5,432,187 |
Benzimidazole anthelmintic in the treatment of microsporidial infections The present inventions relates to the use of certain benzimidazole compounds in the treatment of diseases caused by microsporidia organisms, in particular the... |
| US-5,432,186 |
Cyclic amino acid derivatives Disclosed are the compounds of formula I ##STR1## wherein R represents hydrogen, lower alkyl, carbocyclic or heterocyclic aryl-lower alkyl or... |
| US-5,432,185 |
Haemorheological use of N-alkylated 1,4-dihydropyridine-dicarboxylic
acid esters, and some new compounds Improving circulation, with minimal effect on blood pressure, using N-alkylated 1,4-dihydropyridines of the formula ##STR1## in which R.sup.1 represents... |
| US-5,432,184 |
Microbial inhibiting compositions and their use A biocidal composition and method for inhibiting and controlling the growth of the fungus, Trichoderma viride, are disclosed. The composition comprises an... |
| US-5,432,183 |
Use of rapamycin prodrugs as immunosuppressant agents The use of rapamycin prodrugs of formula I as immunosuppressant agents, intermediates formed in the preparation of its prodrugs as well as the prodrugs... |
| US-5,432,182 |
Compounds substituted quinoline derivatives Substituted 4-aminoquinazoline derivatives which are inhibitors of gastric acid secretion. A compound of the invention are the salts of strong acids of... |
| US-5,432,181 |
Substituted heteroaryl analogs of
4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as
... The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine substituted 1,2,4- and 1,3,4-thiadiazoles and oxadiazoles, and... |
| US-5,432,179 |
Piperazine derivatives and pharmaceuticals containing the same A piperazine derivative represented by the following formula: ##STR1## or a pharmaceutically acceptable salt thereof. The compound according to the present... |
| US-5,432,178 |
Amidinophenol derivatives Amidinophenol derivatives of the formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are (i) H, (ii) C1-4 alkyl, (iii) C1-4 alkoxy, (iv) C2-5 acyl, (v)... |
| US-5,432,177 |
Pyrrolo-pyridine derivatives A class of pyrrolo[2,3-b]pyridine derivatives, substituted at the 3-position by a substituted piperazinylmethyl moiety, are antagonists of dopamine receptor... |
| US-5,432,176 |
Method of retarding the progression of chronic renal failure Progression of chronic renal failure can be retarded or arrested by administering to humans suffering from such disorder an agent which suppresses the production... |
| US-5,432,175 |
Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines
or piperazines, and compositions and... Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines or piperazines and pharmaceutically acceptable salts thereof are disclosed, which possess... |
| US-5,432,174 |
Treatment of ocular hypertension A method for the treatment of ocular hypertension which comprises administering, to a subject in need of such treatment, (a) a .beta.-adrenergic blocker at the... |
| US-5,432,173 |
1-amidooctahydropyrido[2,1,-C][1,4]oxazine compounds The invention relates to the compounds of general formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and A are as defined in the... |
| US-5,432,172 |
Biological applications of alkaloids derived from the tunicate Eudistoma
sp. Biological applications of synthetic and natural alkaloids derived from the tunicate Eudistoma sp. are disclosed. A method regulating cell growth includes... |
| US-5,432,171 |
Water soluble texaphyrin metal complexes for viral deactivation The present invention involves water soluble hydroxy-substituted texaphyrins retaining lipophilicity, the synthesis of such compounds and their uses. These... |
| US-5,432,170 |
Process for the production of semisolid preparations containing
micronized active ingredients A process for the production of semisolid preparations containing micronized active ingredients is described which is characterized in that a mixture of one or... |
| US-5,432,169 |
Cyclopentanperhydrophenanthren-17.beta.-(3-furyl)-3-derivatives and
pharmaceutical compositions comprising same... Cyclopentanperhydrophenantren-17.beta.-(3-furyl)-3-derivatives and pharmaceutical compositions containing same for the treatment of cardiovascular disorders such... |
| US-5,432,168 |
Method of treatment of hormone-unresponsive metastatic prostate cancer Prostate cancer particularly hormone-unresponsive metastatic prostate cancer, is treated by cyclophosphamide or other normally substantially inactive agent.... |
| US-5,432,167 |
Cell proliferation matrix and use thereof A cell proliferation matrix consisting of an aqueous gel of hyaluronic acid or a pharmaceutically acceptable salt thereof which is free from production-related... |
| US-5,432,166 |
Use of 1-(.beta.-D-arabinofuranosyl) -5-propynyluracil for lowering
serum cholesterol The use of 1-(.beta.-D-arabinofuranosyl)-5-propynyluracil or a pharmaceutically acceptable salt or physiologically labile ester thereof for lowering serum... |
| US-5,432,165 |
Methods for the treatment of infection caused by Hepatitis B virus (HBV) The present invention relates to pharmaceutical compositions useful for the treatment of subjects suffering from an infection or disease caused by the hepatitis... |
| US-5,432,164 |
C2,N.sup.6 -disubstituted adenosine derivatives A compound of formula (I), or a pharmaceutically acceptable salt thereof: ##STR1## wherein X is halogen, perhalomethyl, cyano, C.sub.1-6 -alkoxy, C.sub.1-6 ... |
| US-5,432,163 |
Anti-proliferative and anti-inflammatory compounds: derivatives of
pentose monosaccharides Compounds of this invention are derivatives of pentose monosaccharides which exhibit anti-proliferative and anti-inflammatory activity as well as intermediates... |
| US-5,432,162 |
Reducing post-prandial fluctuations in plasma concentrations of large
neutral amino acids (LNAA) Methods of reducing post-prandial fluctuations in plasma levels of large, neutral amino acids (LNAA), as well as compositions useful in that method. The foods... |
| US-5,432,161 |
Crystalline 2-O-.alpha.-d-glucopyranosyl-L-ascorbic acid, and its
preparation and uses 2-O-.alpha.-D-Glucopyranosyl-L-ascrobic acid is crystallizable in its supersaturated solution. Crystalline 2-O-.alpha.-D-glucopyranosyl-L-ascorbic acid is... |
| US-5,432,160 |
Nutrient composition A nutrient composition such as infusions and nutrient preparations, which contains .beta.-alanyl-L-glutamine. |
| US-5,432,159 |
N-(.alpha.-substituted-pyridinyl)carbonyl dipeptide antihypertensive
agents Dipeptide derivatives are taught which are of general formula (I) ##STR1## including tautomeric forms thereof, wherein: n is 0 or an integer of from 1 to... |
| US-5,432,157 |
Chrysospermins, active peptides from apiocrea chrysosperma having a
pharmacological effect and a use thereof The invention relates to the chrysospermin active peptides of the formula I in which x and y, independently of each other, denote Aib or Iva, which are synthesized by... |
| US-5,432,156 |
Therapeutic agent for digestive tract diseases Therapeutic agents for the digestive tract diseases which comprise glicentin as active ingredients. |
| US-5,432,155 |
Conotoxins I Substantially pure conotoxins are provided which inhibit synaptic transmissions at the neuromuscular junctions and which are useful both in vivo and in assays... |
| US-5,432,154 |
Ethers for aromatizing purposes The invention relates to novel ethers and their use as aroma precursors. The ethers are derived from ionol and related compounds. These aroma precursors do not... |
| US-5,432,153 |
Gelling compositions useful for oil field applications A gelling composition and a process for wellbore treatment comprising injecting the composition into reservoirs are disclosed wherein the composition comprises a... |
| US-5,432,152 |
Invert drilling fluid An environmentally friendly invert drilling fluid comprises a water-in-oil emulsion which includes (a) at least 50 volume percent of a low toxicity base oil, and... |
| US-5,432,151 |
Process for ion-assisted laser deposition of biaxially textured layer on
substrate A process for depositing a biaxially aligned intermediate layer over a non-single crystal substrate is disclosed which permits the subsequent deposition thereon... |
| US-5,432,150 |
High-Tc superconducting ceramic oxide products and macroscopic and
microscopic methods of making the same High-Tc superconducting ceramic oxide products and macroscopic and microscopic methods for making such high-Tc superconducting products. Completely sealed... |
| US-5,432,149 |
In-situ tunable Josephson weak links A weak link is patterned from a high-temperature superconducting film using standard lithographic techniques. Once the area in which the weak link is to be... |
| US-5,432,148 |
Slow-release ammonium bicarbonate fungicide compositions This invention provides a fungicide composition which is capable of in situ generation of ammonium bicarbonate when applied to plant foliage in the form of an... |
| US-5,432,147 |
Method of controlling fungal disease in cultivated plants The present invention provides a method for controlling fungal disease in cultivated crops. The aqueous fungicide formulation which is applied to pre-harvest and... |
| US-5,432,146 |
Free-flowing bicarbonate fungicide compositions The present invention provides a fungicidal fertilizer composition which contains ingredients which are biocompatible for purposes of agricultural applications,... |
| US-5,432,145 |
Protective layer transfer sheet A protective layer transfer sheet, including a heat-resistant layer provided on one surface of a substrate film, and an adhesive layer, a releasable protective... |
| US-5,432,144 |
Thermal-transfer recording material and a thermal-transfer recording
process A thermal transfer recordimg material comprising a support having thereon a thermal transfer layer containing a dye represented by the following formula and a... |
| US-5,432,143 |
Method of producing an RBa.sub.2 Cu.sub.3 O.sub.y microcrystalline
structure in which R denotes a lanthanide A method of producing a microcrystalline RBa.sub.2 Cu.sub.3 O.sub.y structure where R denotes a lanthanide chosen from Y, La, Nd, Sm, Eu, Gd, Tb, Ho, Er, Tm, Yb... |
| US-5,432,142 |
Catalyst for alkene dimerization A catalyst composition is disclosed that is useful for the dimerization of a normal 1-alkene containing 3-8 carbons. A supported alkali metal is employed as a... |
| US-5,432,141 |
Preparation of attrition resistant vanadium-antimony oxide catalysts This invention relates to a process for preparing an attrition resistant vanadium-antimony oxide catalyst by adding to a vanadium-antimony oxide catalyst slurry... |
| US-5,432,140 |
Heat curable organopolysiloxane compositions, preformed latent platinum
catalysts, and methods for making Heat curable organopolysiloxane compositions are provided utilizing a vinyl silicone organopolysiloxane fluid, a silicon hydride siloxane and an effective amount... |
Copyright 2008−2012 Patents.com
